Engaging consumers in health research: a narrative review.


Journal

Australian health review : a publication of the Australian Hospital Association
ISSN: 1449-8944
Titre abrégé: Aust Health Rev
Pays: Australia
ID NLM: 8214381

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 09 09 2019
accepted: 24 02 2020
pubmed: 12 8 2020
medline: 22 6 2021
entrez: 12 8 2020
Statut: ppublish

Résumé

Objective Consumer and community engagement (CCE) in research is increasingly valued in a contemporary healthcare environment that seeks to genuinely partner with consumers and the wider community. Although there is widespread agreement at research governance levels as to the benefits of CCE in research, there is little available research-based guidance as to how best to proceed with CCE organisationally and how to manage and overcome barriers. The aim of this narrative review was to draw together the available research, review findings and relevant governance-related material and to discuss these in light of a case series among research-engaged consumers in order to chart a practical way forward. Methods A narrative literature review about CCE in research was conducted. Following this, a case series among seven consumers who had been engaged as partners in health research was conducted. Finally, the lived experience of these consumers was explored against the findings of the narrative review. Results In all, 121 papers were identified and reviewed, 37 of which were used to inform the content of this paper. The most important benefits of CCE to both consumers and healthcare researchers were related to improvements in trust between consumer and researchers, and the increased relevance and ethics of research agendas ultimately pursued. Barriers to CCE were found to be pragmatic, attitudinal and organisational. Enabling factors that capitalise on the benefits and help address the barriers to meaningful CCE are outlined and discussed in light of a case series conducted among research-engaged consumers in Australia and internationally. Conclusion Best practice standards, organisational commitments and resources are needed to improve the status quo in Australia and to provide health research end-users with research outcomes that better align with their priorities and needs. What is known about the topic? Consumer and community engagement (CCE) in research is increasing in prevalence and is likely to be beneficial to both consumers and healthcare providers and researchers. What does this paper add? Following review of the available research findings and governance statements about CCE, enabling strategies are presented in light of a case series among Sydney-based research-engaged consumers. What are the implications for practitioners? Barriers to consumer and community engagement can be overcome if well understood and tackled organisationally. The potential benefits of shifting to a fully consumer- or community-engaged healthcare research environment are multifactorial and represent a paradigm shift in favour of evidence-based patient and family-centred care.

Identifiants

pubmed: 32780985
pii: AH19202
doi: 10.1071/AH19202
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

806-813

Auteurs

Ania Anderst (A)

The George Institute for Global Health, Level 5, 1 King Street, Newtown, NSW 2042, Australia. Email: kconroy@georgeinstitute.org.au; and Corresponding author. Email: aanderst@georgeinstitute.org.au.

Karena Conroy (K)

The George Institute for Global Health, Level 5, 1 King Street, Newtown, NSW 2042, Australia. Email: kconroy@georgeinstitute.org.au; and Sydney Local Health District, Level 11, King George V Building, Missenden Road, Camperdown, NSW 2050, Australia. Email: Greg.Fairbrother@health.nsw.gov.au; Laila.Hallam@health.nsw.gov.au; alan.mcphail@gmail.com; vicki.taylor@health.nsw.gov.au.

Greg Fairbrother (G)

Sydney Local Health District, Level 11, King George V Building, Missenden Road, Camperdown, NSW 2050, Australia. Email: Greg.Fairbrother@health.nsw.gov.au; Laila.Hallam@health.nsw.gov.au; alan.mcphail@gmail.com; vicki.taylor@health.nsw.gov.au; and University of Sydney, Faculty of Medicine and Health, Level 11, King George V Building, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia.

Laila Hallam (L)

Sydney Local Health District, Level 11, King George V Building, Missenden Road, Camperdown, NSW 2050, Australia. Email: Greg.Fairbrother@health.nsw.gov.au; Laila.Hallam@health.nsw.gov.au; alan.mcphail@gmail.com; vicki.taylor@health.nsw.gov.au; and The University of Sydney, Centre for Disability Research and Policy (CDRP), 92-94 Parramatta Road, Camperdown, NSW 2050, Australia.

Alan McPhail (A)

Sydney Local Health District, Level 11, King George V Building, Missenden Road, Camperdown, NSW 2050, Australia. Email: Greg.Fairbrother@health.nsw.gov.au; Laila.Hallam@health.nsw.gov.au; alan.mcphail@gmail.com; vicki.taylor@health.nsw.gov.au.

Vicki Taylor (V)

Sydney Local Health District, Level 11, King George V Building, Missenden Road, Camperdown, NSW 2050, Australia. Email: Greg.Fairbrother@health.nsw.gov.au; Laila.Hallam@health.nsw.gov.au; alan.mcphail@gmail.com; vicki.taylor@health.nsw.gov.au; and University of Sydney, Faculty of Medicine and Health, Level 11, King George V Building, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH